Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Maria Rita Migliorino
ResearcherPublications, citations & collaboration network
Maria Rita Migliorino is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 80 works, 5,175 citations, an h-index of 31 and an i10-index of 50.
80
Works
5,175
Citations
31
h-index
50
i10-index
IDs:OpenAlex
How has Maria Rita Migliorino's publication output changed over time?
ScholarIQpublication output · 2005–2021
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2021.
1
1
1
1
4
2
1
2005201420172018201920202021
What are the most-cited papers on Maria Rita Migliorino?
ScholarIQmost cited works
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
Yi‐Long Wu, Ying Cheng, Xiangdong Zhou, Ki Hyeong Lee, Kazuhiko Nakagawa, Seiji Niho, Fumito Tsuji, R. Linke, Rafael Rosell, J. Corral, Maria Rita Migliorino, Adam Płużański, Eric Sbar, Tao Wang, Jane Liang White, Sashi Nadanaciva, Rickard Sandin, Tony Mok
The Lancet Oncology. 20171,219 Citations
Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study
Paolo Maione, Francesco Perrone, Ciro Gallo, Luigi Manzione, Francovito Piantedosi, Santi Barbera, S. Cigolari, Francesco Rosetti, Elena Piazza, Sergio Robbiati, Oscar Bertetto, Silvia Novello, Maria Rita Migliorino, Adolfo Favaretto, Mario Spatafora, Francesco Ferraù, Luciano Frontini, Alessandra Bearz, Lazzaro Repetto, Cesare Gridelli
Journal of Clinical Oncology. 2005478 CitationsOPEN ACCESS
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and <i>EGFR</i>-Activating Mutations
Tony Mok, Ying Cheng, Xiangdong Zhou, Ki Hyeong Lee, Kazuhiko Nakagawa, Seiji Niho, Min Lee, R. Linke, Rafael Rosell, J. Corral, Maria Rita Migliorino, Adam Płużański, Eric Sbar, Tao Wang, Jane Liang White, Yi‐Long Wu
Journal of Clinical Oncology. 2018439 Citations
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies
Chiara D’Antonio, Antonio Passaro, Bruno Gori, Ester Del Signore, Maria Rita Migliorino, Serena Ricciardi, Alberto Fulvi, Filippo de Marinis
S41085503. 2014224 CitationsOPEN ACCESS
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
Alessio Cortellini, Sebastiano Buti, Daniele Santini, Fabiana Perrone, Raffaele Giusti, Marcello Tiseo, Melissa Bersanelli, Maria Michiara, Antonino Grassadonia, Davide Brocco, Nicola Tinari, Michele De Tursi, Federica Zoratto, Enzo Veltri, Riccardo Marconcini, Francesco Malorgio, Carlo Garufi, Marco Russano, Cecilia Anesi, Tea Zeppola, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Gian Carlo Antonini Cappellini, Federica De Galitiis, Maria Giuseppa Vitale, Roberto Sabbatini, Sergio Bracarda, Rossana Berardi, Silvia Rinaldi, Marianna Tudini, Rosa Rita Silva, Annagrazia Pireddu, Francesco Atzori, Rita Chiari, Biagio Ricciuti, Daniela Iacono, Maria Rita Migliorino, Antônio Rossi, Giampiero Porzio, Katia Cannita, Valeria Ciciarelli, Maria Concetta Fargnoli, Paolo A. Ascierto, Corrado Ficorella
The Oncologist. 2019221 CitationsOPEN ACCESS
Related on ScholarIQ
Nini Hospital
Institution
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
Paper
Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study
Paper
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and <i>EGFR</i>-Activating Mutations
Paper
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies
Paper
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
Paper